Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas (Q31043472)

28 June 2017

title

Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas (English)

1 reference

Fluorodeoxyglucose Positron Emission Tomography

28 June 2017

main subject

1 reference

Dominique Figarella-Branger

inferred from title

author

ORCID Public Data File 2021

object named as

Dominique Figarella-Branger

0 references

Julien Mancini

0 references

Olivier Chinot

1 reference

author name string

Cécile Colavolpe

1 reference

28 June 2017

Philippe Metellus

1 reference

28 June 2017

Maryline Barrie

1 reference

28 June 2017

Céline Béquet-Boucard

1 reference

28 June 2017

Olivier Mundler

1 reference

28 June 2017

Eric Guedj

1 reference

28 June 2017

publication date

15 December 2011

1 reference

Journal of Neuro-Oncology

28 June 2017

published in

1 reference

28 June 2017

volume

107

1 reference

28 June 2017

1 reference

28 June 2017

page(s)

527-535

1 reference

The 2007 WHO classification of tumours of the central nervous system

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Primary brain tumours in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Observer reliability in histological grading of astrocytoma stereotactic biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

FDG-PET as a prognostic factor in high-grade astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Positron emission tomography in patients with glioma. A predictor of prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Perfusion and metabolism in predicting the survival of patients with cerebral gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Prediction of survival in glioma patients by means of positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Prediction of pathology and survival by FDG PET in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

FDG-PET to predict different patterns of progression in multicentric glioblastoma: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

High and low grade oligodendrogliomas (ODG): correlation of amino-acid and glucose uptakes using PET and histological classifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Comparison of visual and ROI-based brain tumour grading using 18F-FDG PET: ROC analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

[11C] methionine and [18F] fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Over-expression of facilitative glucose transporter genes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Regulation of hexokinase in cultured gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Positron emission tomography with injection of methionine as a prognostic factor in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

FDOPA PET has clinical utility in brain tumour imaging: a proposal for a revision of the recent EANM guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0771-6

18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.

21 January 2018

1 reference

12 December 2020

Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution

1 reference

12 December 2020

Can the standardized uptake value characterize primary brain tumors on FDG-PET?

1 reference

12 December 2020

Oxygen consumption and anaerobic glycolysis of human malignant and normal tissue

1 reference

12 December 2020

18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy

1 reference

12 December 2020

Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies

1 reference

12 December 2020

Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors

1 reference

12 December 2020

Correlation of FDG-PET interpretation with survival in a cohort of glioma patients

1 reference

12 December 2020

Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool

1 reference

12 December 2020

Which glioblastoma multiforme patient will become a long-term survivor? A population-based study

1 reference

12 December 2020

F-Dopa as an amino acid tracer to detect brain tumors.

1 reference

12 December 2020

[Magnetic resonance spectroscopy in gliomas].

1 reference

12 December 2020

18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma

1 reference

12 December 2020

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

1 reference

12 December 2020

2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome

1 reference

12 December 2020

Validity of PET studies in brain tumors.

1 reference

12 December 2020

Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine

1 reference

12 December 2020

10.1007/S11060-011-0771-6

Identifiers

DOI

1 reference

Dimensions Publication ID

28 June 2017

1026916955

0 references

1 reference